Health Care

885 posts

" BioVaxys (CSE:BIOV) files patent for pan-sarbecovirus vaccine

BioVaxys Technology (BIOV) has filed a provisional patent application for its viral antigen vaccine platform.

" Datametrex (TSXV:DM) launches smartphone health app

Datametrex AI (DM) subsidiary Medi-Call MD has officially launched a closed beta test for its Medi-Call health app.
Avicanna Inc - CEO, Aras Azadian.

" Avicanna (TSX:AVCN) closes private placement

Avicanna (AVCN) has closed a non-brokered private placement for gross proceeds of approximately $3.9 million.

" Small Pharma (TSXV:DMT) doses first patient in trial

Small Pharma Inc. (DMT) has dosed the first patient of its Phase IIa clinical trial for its lead N,N-dimethyltryptamine candidate, SPL026.

" BioSyent (TSXV:RX) subsidiary launches new FeraMAX® Powder 15

BioSyent Inc. (RX) subsidiary BioSyent Pharma lanches FeraMAX® Pd Powder 15 in Canada.
Field Trip Health - President, Hannan Fleiman.

" Field Trip Health (TSX:FTRP) announces three new therapy centers

Field Trip Health (FTRP) is announcing new psychedelic-assisted therapy centers in Seattle, Vancouver and Fredericton.
Levitee Labs - CEO, Pouya Farmand.

" Levitee Labs (CSE:LVT) partners with Adracare for addiction and mental health support

Levitee Labs (LVT) has signed an agreement with Adracare to develop a platform for mental health services.

" Cardiol Therapeutics (TSX:CRDL) expands phase II/III trial of CardiolRx

Cardiol Therapeutics (CRDL) is expanding its LANCER trial to include several hospital centers in Brazil, Mexico, and Canada.

" XORTX Therapeutics (CSE:XRX) closes public offering

XORTX Therapeutics (XRX) announced the closing of a US$12M public offering.

" Marvel Biosciences (TSXV:MRVL) updates the status of its MB-204 manufacturing efforts

Marvel Biosciences Corp. (MRVL) reports a successful process development of the active pharmaceutical ingredient of its lead drug MB-204.

" Reliq Health Technologies (TSXV:RHT) adds over 3,600 new patients

Reliq Health Technologies Inc. (RHT) has signed contracts with three primary care physician practices in Puerto Rico.

" ScreenPro Security (CSE:SCRN) upgrades U.S. listing to OTCQB

ScreenPro Security (SCRN) has upgraded its US listing from the OTC Pink Sheets to the OTCQB Venture Market.

" PharmaDrug (CSE:PHRX) announces positive research results for cancer treatment

PharmaDrug (PHRX) has completed a preclinical study on the effectiveness of the drug cepharanthine-2HCl.

" Manganese X Energy (TSXV:MN) subsidiary Disruptive Battery reports positive results from research on fighting pathogens and biofilm

­­Manganese X Energy Corp. (MN) announced that its subsidiary has reported positive results from long-term research on fighting pathogens and biofilm.
The Market Herald Video

" Appili Therapeutics (TSX:APLI) closes $7 million overnight offering

Appili Therapeutics (APLI) has closed its

" Vaxil Bio Ltd. (TSXV:VXL) signs letter of intent to acquire ShortWave Pharma Inc.

Vaxil (VXL), a biotech company, has signed a non-binding letter of intent to acquire a 100 per cent stake in ShortWave Pharma.
Levitee Labs - CEO, Pouya Farmand.

" Levitee Labs (CSE:LVT) appoints new Chief People Officer

Levitee Labs Inc (LVT) appoints Mohammed H Mosli, MD, FRCPC, ISAM, as Chief People Officer (CPO) of Levitee Clinics™ and Levitee Pharmacies™.

" Clearmind Medicine (CSE:CMND) appoints distinguished addiction experts to its scientific advisory board

Clearmind Medicine (CMND) has appointed professors Wim van den Brink and Gabriele Fischer to the company’s scientific advisory board.
Appili Therapeutics - CEO, Armand Balboni.

" Appili Therapeutics (TSX:APLI) announces $7 million overnight offering

Appili Therapeutics (APLI) has announced a C$7 million overnight marketed offering of equity securities.
XORTX Therapeutics - CEO, Allen Davidoff.

" XORTX Therapeutics (CSE:XRX) announces Nasdaq listing and $12 million public offering

XORTX (XRX) begins trading today on the Nasdaq Capital Market in conjunction with a US$12 million public offering.